"Iron Overload and Endocrinological Diseases"

Launched by AZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA · Nov 13, 2023

Keywords

ClinConnect Summary

This clinical trial, titled "Iron Overload and Endocrinological Diseases," is studying how excess iron in the body affects hormonal health in adults with conditions like β-thalassemia or hemochromatosis. These conditions can lead to too much iron accumulation, which can damage various organs, including the heart and liver, and may cause problems with hormone production. The researchers want to find out how common these hormone-related health issues are in patients with iron overload and how they impact people's overall well-being and quality of life.

To participate in this study, adults aged 18 to 65 who have a confirmed diagnosis of either β-thalassemia major or intermedia, or hereditary hemochromatosis, are eligible. Participants will undergo evaluations that include a review of their medical history, a physical exam, hormone level tests, and other necessary health checks. This study aims to gather important information that could help doctors better understand and treat endocrine problems in patients with iron overload. If you or someone you know fits the criteria and is interested, this could be an opportunity to contribute to valuable research in this area.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Certain diagnosis of β-thalassemia major or intermedia
• • Certain diagnosis of Hereditary Hemochromatosis
• • Adult patients with an age between 18 and 65 years
• Exclusion Criteria:
• • Subjects with an age \< 18 and \> 65 years